- Corporate Officers - L
- Leonhardt Harry J
Insider Trading History of Leonhardt Harry J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Leonhardt Harry J since 2005.
The trader's CIK number is 1286102.
At the time of the last reporting, Leonhardt Harry J was the SVP, Gen Counsel & C of Halozyme Therapeutics, Inc.. (stock ticker symbol HALO).
Also see all insider trading activities at Halozyme Therapeutics, Inc..
Note that in the past
LEONHARDT HARRY J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Senomyx Inc (SNMX) by Leonhardt Harry J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | SNMX | 0 | $0 | 19,980 | $279,445 | 0 | $0 |
| 2006 | SNMX | 0 | $0 | 26,140 | $397,944 | 0 | $0 |
| 2005 | SNMX | 0 | $0 | 5,092 | $101,530 | 0 | $0 |
Yearly summary of insider trading at Amylin Pharmaceuticals Inc (AMLN) by Leonhardt Harry J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | AMLN | 0 | $0 | 3,411 | $58,187 | 0 | $0 |
Yearly summary of insider trading at Halozyme Therapeutics, Inc. (HALO) by Leonhardt Harry J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | HALO | 0 | $0 | 0 | $0 | 41,489 | $0 |
| 2018 | HALO | 0 | $0 | 0 | $0 | 33,680 | $0 |
| 2017 | HALO | 0 | $0 | 0 | $0 | 22,288 | $0 |
| 2016 | HALO | 0 | $0 | 0 | $0 | 6,875 | $0 |
Insider trading activities at 3 companies by Leonhardt Harry J:
1. Senomyx Inc (SNMX)
2. Amylin Pharmaceuticals Inc (AMLN)
3. Halozyme Therapeutics, Inc. (HALO)
Table 1. Insider trading of Senomyx Inc (SNMX) by Leonhardt Harry J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-09-04 | SNMX | Sale | 228 | 13.25 | 3,020 |
| 2007-07-16 | SNMX | Sale | 1,500 | 13.64 | 20,464 |
| 2007-06-15 | SNMX | Sale | 10,500 | 14.84 | 155,862 |
| 2007-05-15 | SNMX | Sale | 1,500 | 12.47 | 18,703 |
| 2007-04-16 | SNMX | Sale | 4,752 | 13.08 | 62,151 |
| 2007-01-16 | SNMX | Sale | 1,500 | 12.83 | 19,245 |
| 2006-11-15 | SNMX | Sale | 3,000 | 14.88 | 44,649 |
| 2006-09-15 | SNMX | Sale | 2,500 | 15.04 | 37,602 |
| 2006-09-01 | SNMX | Sale | 954 | 14.96 | 14,270 |
| 2006-08-15 | SNMX | Sale | 1,000 | 13.40 | 13,405 |
| 2006-07-17 | SNMX | Sale | 1,000 | 13.11 | 13,107 |
| 2006-05-15 | SNMX | Sale | 1,000 | 12.78 | 12,777 |
| 2006-04-17 | SNMX | Sale | 1,000 | 14.58 | 14,580 |
| 2006-03-15 | SNMX | Sale | 2,000 | 15.78 | 31,560 |
| 2006-03-01 | SNMX | Sale | 4,166 | 16.43 | 68,434 |
| 2006-02-15 | SNMX | Sale | 9,520 | 15.50 | 147,560 |
| 2005-09-15 | SNMX | Sale | 1,880 | 17.85 | 33,565 |
| 2005-07-26 | SNMX | Sale | 3,212 | 21.16 | 67,965 |
Table 2. Insider trading of Amylin Pharmaceuticals Inc (AMLN) by Leonhardt Harry J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-01 | AMLN | Sale | 1,231 | 17.11 | 21,062 |
| 2012-02-23 | AMLN | Sale | 2,180 | 17.03 | 37,125 |
Table 3. Insider trading of Halozyme Therapeutics, Inc. (HALO) by Leonhardt Harry J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-04-13 | HALO | Option Ex | 6,875 | .00 | 0 |
| 2019-02-22 | HALO | Option Ex | 11,392 | .00 | 0 |
| 2019-02-14 | HALO | Option Ex | 7,809 | .00 | 0 |
| 2019-02-03 | HALO | Option Ex | 15,413 | .00 | 0 |
| 2018-04-13 | HALO | Option Ex | 6,875 | .00 | 0 |
| 2018-02-22 | HALO | Option Ex | 11,392 | .00 | 0 |
| 2018-02-03 | HALO | Option Ex | 15,413 | .00 | 0 |
| 2017-04-13 | HALO | Option Ex | 6,875 | .00 | 0 |
| 2017-02-03 | HALO | Option Ex | 15,413 | .00 | 0 |
| 2016-04-13 | HALO | Option Ex | 6,875 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Leonhardt Harry J
(SVP, Gen Counsel & C of Halozyme Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.